it will boost blood supply to sexual genitalia

Pfizer, aware of the amount of money they made with the Viagra erectile dysfunction medication for men have been busy investing millions of pounds in researching and developing a female equivalent.

Their latest offering which is codenamed UK-414,495 is designed to work in the same way that Viagra does in that it will boost blood supply to sexual genitalia. So far the research on the UK-414,495 prototype has only involved animal testing but Pfizer are confident that the tablets might be able to help women suffering from female sexual dysfunction.

Professor Chris Wayman leading the research, said that they had discovered a lot about the processes involved in female sexual functioning and that they were hoping that in the future they could develop a drug which would be effective and safe like Viagra.

The research by Pfizer which is published in full by the British Journal of Pharmacology does not necessarily mean that women should be jumping for joy because they warned that the drug might not work for humans. In fact, at Ukmedix News we have seen women's hopes being raised and then dashed when promising research ends up producing poor results.

Pfizer also admitted that the experimental drug will not have an effect on levels of sexual desire in women which are often controlled by mood and emotions. In fact many scientists argue that what women need to cure sexual problems is not a drug that boost blood supply like Viagra does for men, but a drug which will cure the psychological and emotional issues that women often have with sex.

At present the only drug available to treat women suffering from female sexual dysfunction is the drug Intrinsa which releases hormones which are known to boost to sexual desire in women into the bloodstream. Intrinsa is a prescription medication and is the only female sexual dysfunction drug licensed for sale in the UK.